METTL14 and neoplasm: Given that the potential of miRNAs as therapeutic targets [44], targeting miR-3165 might be a potential therapeutic strategy in BCa treatment since it causes a subsequent decrease in METTL14 expression, further leading to the promotion of cell migration, invasion and EMT as well as tumor metastasis in BCa.